MedTrace Logo

Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System

NCT02426489 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-10-07

No results posted yet for this study

Summary

The purpose of the study is to assess whether the addition of positron emission mammography will add diagnostic value to magnetic resonance imaging of the breast, in patients with lesions of the breast that are suspicious enough to warrant biopsy, or which have been confirmed as containing cancer cells.

Conditions

Interventions

DEVICE

MRI + PEM image

Effect of positron emission mammography on diagnostic accuracy

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • Weinberg Medical Physics LLC

    lead INDUSTRY

Principal Investigators

  • Irving Weinberg, MD PhD · Weinberg Medical Physics LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2016-05-08
Completion
2016-05-08

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02426489 on ClinicalTrials.gov